Related Experiment Video

Updated: Oct 18, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS
08:38

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

[Hepatotoxicity of cyclosporine in patients with kidney transplants]

J Karamehić1, M Ascerić, T Tulumović

  • 1Zavod za farmakologiju i toksikologiju sa klinickom farmakologijom, Medicinski fakultet Univerziteta u Tuzli.

Medicinski Arhiv
|December 11, 1999
PubMed

Insights

This study monitored liver transaminases in kidney transplant patients on cyclosporine therapy. Adjusting cyclosporine dosage normalized elevated liver enzymes, highlighting the importance of monitoring immunosuppressive drug levels.

Area of Science:

  • Nephrology
  • Hepatology
  • Pharmacology

Context:

  • Kidney transplant recipients often require long-term immunosuppression with cyclosporine.
  • Cyclosporine is known to potentially cause liver and kidney toxicity with prolonged use.
  • Patient management challenges arose due to lack of cyclosporine monitoring during wartime.

Purpose:

  • To analyze liver transaminases levels in kidney transplant patients undergoing cyclosporine therapy.
  • To investigate the correlation between cyclosporine dosage and liver enzyme levels.
  • To assess the impact of cyclosporine therapy adjustments on liver function.

Summary:

  • Liver transaminases were analyzed in 15 kidney transplant patients on cyclosporine.
  • One patient exhibited elevated liver transaminases, which normalized after cyclosporine therapy correction.
  • The study underscores the necessity of therapeutic drug monitoring for cyclosporine.

Impact:

  • Highlights the potential hepatotoxicity of cyclosporine in kidney transplant patients.
  • Emphasizes the critical role of regular monitoring and dose adjustment of cyclosporine for patient safety.
  • Provides insights into managing immunosuppressive therapy in challenging circumstances, such as wartime.

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...